HOOKIPA Pharma Inc. (HOOK)
2025-03-31 | 2024-09-30 | 2024-06-30 | ||
|---|---|---|---|---|
| Revenue from collaboration and licensing | 2,004 | 4,703 | 1,290 | |
| Impairment of long-lived assets to be disposed of | - | 172 | - | |
| Restructuring | 133 | 878 | 54 | |
| Research and development | 12,859 | 15,565 | 19,749 | |
| General and administrative | 6,886 | 6,732 | 3,945 | |
| Total operating expenses | 19,878 | 23,347 | 23,748 | |
| (loss) income from operations | -17,874 | -18,644 | -22,458 | |
| Other income (expense), net | 1,984 | 1,811 | -218 | |
| Interest income | 236 | 809 | 1,073 | |
| Grant income | 227 | 2,183 | 2,508 | |
| Total other income, net | 2,447 | 4,803 | 3,363 | |
| Net (loss) income before tax | -15,427 | -13,841 | -19,095 | |
| Net (loss) income | -15,427 | -13,841 | -19,095 | |
| Foreign currency translation (loss) gain, net of tax | -1,354 | -1,360 | 178 | |
| Comprehensive (loss) income | -16,781 | -15,201 | -18,917 | |
| Basic eps | -1.23 | -1.1 | -1.52 | |
| Diluted eps | -1.23 | -1.1 | -1.52 | |
| Basic average shares | 12,544,777 | 12,538,774 | 12,538,774 | |
| Diluted average shares | 12,544,777 | 12,538,774 | 12,538,774 | |